Option Care Health (NASDAQ:OPCH) Updates FY 2025 Earnings Guidance

Option Care Health (NASDAQ:OPCH) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 1.590-1.690 for the period, compared to the consensus estimate of 1.330. The company issued revenue guidance of $5.3 billion-$5.5 billion, compared to the consensus revenue estimate of $5.3 billion.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and lifted their target price for the company from $26.00 to $33.00 in a report on Monday, January 13th. UBS Group assumed coverage on Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price on the stock. JPMorgan Chase & Co. upped their price target on Option Care Health from $38.00 to $40.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price target (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Finally, Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and boosted their price objective for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, Option Care Health presently has an average rating of “Moderate Buy” and a consensus price target of $32.88.

Option Care Health Stock Up 0.5 %

Option Care Health stock opened at $34.12 on Wednesday. The stock’s 50 day moving average price is $29.15 and its 200 day moving average price is $28.09. Option Care Health has a 1-year low of $21.39 and a 1-year high of $34.57. The company has a market cap of $5.81 billion, a PE ratio of 28.67, a price-to-earnings-growth ratio of 2.30 and a beta of 1.35. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Insiders Place Their Bets

In other news, insider Michael Bavaro sold 30,996 shares of the business’s stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company’s stock, valued at $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.64% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.